Binge Eating Disorder
📧 Sign up to get email alerts when something new happens for Binge Eating Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-06FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Bariatric Surgery and Guided Self-help for Binge Eating Disorder [NA]
This clinical trial update notes the termination of a study evaluating bariatric surgery in combination with guided self-help for obesity an…
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Uniting Couples In the Treatment of Eating Disorders (UNITE) [NA]
The UNITE trial conducted by University of North Carolina Chapel Hill has completed, but no results are reported in this update.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Acceptance-based Group Intervention for Binge Eating [NA]
A clinical trial evaluated an acceptance-based group intervention for binge eating, with results posted after study completion.
-
CLINICAL_TRIALS research · 2016-10-04Clinical Trial Update: Stepped Care for Binge Eating Disorder: Predicting Response to Minimal Intervention in a Randomized Controlled Trial [NA]
A clinical trial update on a randomized controlled trial evaluating stepped care with minimal intervention for Binge Eating Disorder and att…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED) [Phase 2]
A Phase 2 clinical trial evaluating phentermine/topiramate extended-release for binge eating disorder has completed. The study was sponsored…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Description and Evaluation of Eating Disorders in Elite Athletes (TCA SHN)
A clinical trial update notes that the study on describing and evaluating eating disorders in elite athletes (TCA SHN) has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder [Phase 3]
A Phase 3 efficacy study of lisdexamfetamine for binge eating disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Engaging Latino Families in Eating Disorders Treatment [NA]
A clinical trial update indicates the study on engaging Latino families in eating disorders treatment has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Smartphone Technology and CBT-GSH in Binge Eaters [Phase 1]
Phase 1 trial evaluating smartphone-based CBT-GSH for binge eating disorders has completed; no efficacy results are provided in the summary.
-
FDA approval · 2016-04-15FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc. unde…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Phase 3]
Phase 3 trial update on SPD489 for maintenance of efficacy in adults with moderate to severe binge eating disorder has completed with posted…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care [NA]
Completed randomized trial comparing behavioral weight loss to stepped care for obesity and binge eating; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Lisdexamfetamine in Binge Eating Disorder (BED): fMRI Effects [Phase 2]
Phase 2 trial investigating the effects of lisdexamfetamine on binge eating disorder with functional MRI measurements.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Open Label Extension in Adults With Binge Eating Disorder (BED) [Phase 3]
Open-label extension study in adults with Binge Eating Disorder completed; results posted in 2015.
-
FDA approval · 2015-12-04FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS research · 2015-11-26Clinical Trial Update: Reduction of the Speed of Eating as an Intervention in Obesity [Phase 1]
Phase 1 trial evaluating whether slowing the speed of eating can help treat obesity, including individuals with Binge-Eating Disorder; the s…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: Armodafinil in Binge Eating Disorder (BED) [Phase 3]
Phase 3 clinical trial of armodafinil for Binge Eating Disorder has completed. The update notes the study status but does not provide result…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: An Integrative Intervention for Loss of Control Eating Among Adolescent Girls [NA]
This clinical trial update reports the completion of a study evaluating an integrative intervention for loss of control eating in adolescent…
-
FDA approval · 2015-01-30FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Treatment of Binge Eating in Obese Patients in Primary Care [Phase 4]
Phase 4 trial update on treatment of binge eating in obese patients in primary care; study completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Phase 3]
Phase 3 trial update for SPD489 in adults with moderate to severe binge eating disorder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-07-21Clinical Trial Update: SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder [Phase 3]
Phase 3 trial update for SPD489 in adults with moderate to severe binge eating disorder has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Effectiveness of Binge Eating Disorder Treatments [Phase 4]
Phase 4 trial update assessing the effectiveness of binge eating disorder treatments, completed at Stanford University.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Craving, Binge Eating and Obesity [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study addressing craving, binge eating, and obesity; completed with results posted in 2014.